Register Cart 0

Generic placeholder image

Current Gene Therapy

Editor-in-Chief

ISSN (Print): 1566-5232
ISSN (Online): 1875-5631

Back Subscribe

Editorial [Hot Topic: Herpes Simplex Virus Type 1-Based Amplicons Vectors (Guest Editor: Alberto L. Epstein)]

Author(s): Alberto L. Epstein

Volume 6, Issue 3, 2006

Page: [275 - 276] Pages: 2

DOI: 10.2174/156652306777592072

Next »

Rights & Permissions Print Cite

Article Metrics

11

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

5-HT5 Receptors
Current Drug Targets - CNS & Neurological Disorders

Targeting Proteasomes with Naturally Occurring Compounds in Cancer Treatment
Current Cancer Drug Targets

The Urokinase Receptor Interactome
Current Pharmaceutical Design

Anti-Cancer/Anti-Tumor
Current Bioactive Compounds

Novel Agents Aiming at Specific Molecular Targets Increase Chemosensitivity and Overcome Chemoresistance in Hematopoietic Malignancies
Current Pharmaceutical Design

Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy
Current Cancer Therapy Reviews

Hsp90: A Novel Target for Cancer Therapy
Current Topics in Medicinal Chemistry

Use of Carbohydrate-Conjugated Nanoparticles for an Integrated Approach to Functional Imaging of Glycans and Understanding of their Molecular Mechanisms
Current Pharmaceutical Biotechnology

Cancer-Homing Toxins
Current Pharmaceutical Design

Exercise-Induced Overexpression of Angiogenic Factors and Reduction of Ischemia / Reperfusion Injury in Stroke
Current Neurovascular Research

ABC Transporters in the CNS – An Inventory
Current Pharmaceutical Biotechnology

The Sleeping Beauty Transposon Vector System for Treatment of Rare Genetic Diseases: An Unrealized Hope?
Current Gene Therapy

Characterization of Molecular and Functional Alterations of Tumor Endothelial Cells to Design Anti-Angiogenic Strategies
Current Vascular Pharmacology

Recent Patents on Proteasome Inhibitors of Natural Origin
Recent Patents on Anti-Cancer Drug Discovery

Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
Current Drug Targets

Modified Polysaccharides as Carriers for Biomolecules
Pharmaceutical Nanotechnology

Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight
Current Neuropharmacology

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets

Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design

Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy
Current Drug Targets

© 2024 Bentham Science Publishers | Privacy Policy